XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Stockholders' Equity
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
4.
STOCKHOLDERS’ EQUITY
 
Stock-based compensation is estimated at the grant date based on the award’s fair value and is recognized on a straight-line basis over the vesting periods, generally
four
years
.
Stock-based compensation expense before taxes related to the Company’s stock plans and employee stock purchase plan was allocated as follows (in thousands): 
 
   
Three Months
Ended June 30,
   
Six Months
Ended June 30,
 
   
2018
   
2017
   
2018
   
2017
 
Cost of Design-to-silicon yield-solutions
  $
968
    $
1,069
    $
1,981
    $
2,261
 
Research and development
   
845
     
848
     
1,724
     
1,682
 
Selling, general and administrative
   
889
     
987
     
1,852
     
1,845
 
Stock-based compensation expenses
  $
2,702
    $
2,904
    $
5,557
    $
5,788
 
 
On
June 30, 2018,
the Company had the following stock-based compensation plans:
 
Stock Plans —
At the annual meeting of stockholders on
November 16, 2011,
the Company’s stockholders approved the
2011
Stock Incentive Plan, which was most recently amended and restated at the
2017
annual meeting of stockholders on
May 31, 2017,
when the Company’s stockholders approved the Fourth Amended and Restated
2011
Stock Incentive Plan (as amended, the
“2011
Plan”). Under the
2011
Plan, the Company
may
award stock options, stock appreciation rights, stock grants or stock units covering shares of the Company's common stock to employees, directors, non-employee directors and contractors. The aggregate number of shares reserved for awards under this plan is
7,800,000
shares, plus up to
3,500,000
shares previously issued under the
2001
Plan that are forfeited or repurchased by the Company or shares subject to awards previously issued under the
2001
Stock Plan (the
"2001
Plan") that expire or that terminate without having been exercised or settled in full on or after
November 16, 2011.
In case of awards other than options or stock appreciation rights, the aggregate number of shares reserved under the plan will be decreased at a rate of
1.33
shares issued pursuant to such awards. The exercise price for stock options must generally be at prices
no
less than the fair market value at the date of grant. Stock options generally expire
ten
years from the date of grant and become vested and exercisable over a
four
-year period.
 
In
2001,
the Company adopted a
2001
Plan. In
2003,
in connection with its acquisition of IDS Systems Inc., the Company assumed IDS’
2001
Stock Option / Stock Issuance Plan (the “IDS Plan”). Both of the
2001
and the IDS Plans expired in
2011.
Stock options granted under the
2001
and IDS Plans generally expire
ten
years from the date of grant and become vested and exercisable over a
four
-year period. Although
no
new awards
may
be granted under the
2001
or IDS Plans, awards made under the
2001
and IDS Plans that are currently outstanding remain subject to the terms of each such plan.   
 
As of
June 30, 2018,
9.6
million shares of common stock were reserved to cover stock-based awards under the
2011
Plan, of which
4.1
million shares were available for future grant. The number of shares reserved and available under the
2011
Plan includes
0.5
million shares that were subject to awards previously made under the
2001
Plan which were forfeited, expired or repurchased by the Company after adoption of the
2011
Plan through
June 30, 2018.
As of
June 30, 2018,
there were
no
outstanding awards that had been granted outside of the
2011,
2001
or the IDS Plans (collectively, the "Stock Plans"). 
   
The Company estimated the fair value of share-based awards granted under the
2011
Stock Plan during the period using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions, resulting in the following weighted average fair values: 
 
   
Three Months
Ended June 30,
   
Six Months
Ended June 30,
 
   
2018
         
2017
   
2018
   
2017
 
Expected life (in years)
   
-
           
4.41
     
4.43
     
4.41
 
Volatility
   
-
           
41.63
%
   
42.22
%
   
41.53
%
Risk-free interest rate
   
-
           
1.67
%
   
2.52
%
   
1.69
%
Expected dividend
   
-
           
-
     
-
     
-
 
Weighted average fair value per share of options granted during the period
  $
-
          $
5.98
    $
4.28
    $
6.16
 
 
No
stock options were granted during the
three
months ended
June 30, 2018.
 
Stock option activity under the Company’s Stock Plans during the
six
months ended
June 30, 2018,
was as follows:
 
   
Number of
Options
(in
thousands)
   
Weighted
Average
Exercise
Price per
Share
   
Weighted
Average
Remaining
Contractual
Term (years)
   
Aggregate
Intrinsic
Value
(in
thousands)
 
Outstanding, January 1, 2018
   
1,045
    $
9.65
     
 
     
 
 
Granted (weighted average fair value of $4.28 per share)
   
10
    $
11.26
     
 
     
 
 
Exercised
   
(59
)   $
7.069
     
 
     
 
 
Canceled
   
(6
)   $
14.02
     
 
     
 
 
Expired
   
(4
)   $
16.22
     
 
     
 
 
Outstanding, June 30, 2018
   
986
    $
9.80
     
4.51
    $
3,404
 
Vested and expected to vest, June 30, 2018
   
977
    $
9.71
     
4.44
    $
3,403
 
Exercisable, June 30, 2018
   
808
    $
8.50
     
3.56
    $
3,380
 
   
The aggregate intrinsic value in the table above represents the total intrinsic value based on the Company’s closing stock price of
$11.98
per share as of
June 30, 2018.
The total intrinsic value of options exercised during the
six
months ended
June 30, 2018,
was
$0.3
million.
 
As of
June 30, 2018,
there was
$0.9
million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted average period of
3.0
years. The total fair value of shares vested during the
six
months ended
June 30, 2018,
was
$0.2
million.
 
Restricted stock unit activity during the
six
months ended
June 30, 2018,
was as follows:
 
   
Shares
(in thousands)
   
Weighted
Average Grant
Date Fair Value
Per Share
 
Outstanding, January 1, 2018
   
1,617
    $
15.66
 
Granted
   
10
    $
11.26
 
Vested
   
(332
)   $
16.19
 
Forfeited
   
(84
)   $
15.53
 
Outstanding, June 30, 2018
   
1,211
    $
15.49
 
   
As of
June 30, 2018,
there was
$15.3
million of total unrecognized compensation cost related to outstanding restricted stock units. That cost is expected to be recognized over a weighted average period of
2.3
years. Restricted stock units do
not
have rights to dividends prior to vesting.
  
Employee Stock Purchase Plan
— In
July 2001,
the Company adopted a
ten
-year Employee Stock Purchase Plan (as amended, the “Purchase Plan”) under which eligible employees can contribute up to
10%
of their compensation, as defined in the Purchase Plan, towards the purchase of shares of PDF common stock at a price of
85%
of the lower of the fair market value at the beginning of the offering period or the end of the purchase period. The Purchase Plan consists of
twenty-four
-month offering periods with
four six
-month purchase periods in each offering period. Under the Purchase Plan, on
January 1
of each year, starting with
2002,
the number of shares reserved for issuance will automatically increase by the lesser of (
1
675,000
 shares, (
2
2%
of the Company’s outstanding common stock on the last day of the immediately preceding year, or (
3
) the number of shares determined by the board of directors. At the annual meeting of stockholders on
May 18, 2010,
the Company’s stockholders approved an amendment to the Purchase Plan to extend it through
May 17, 2020. 
   
The Company estimated the fair value of purchase rights granted under the Purchase Plan during the period using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions, resulting in the following weighted average fair values:
 
   
Six Months
Ended June 30,
 
   
2018
   
2017
 
Expected life (in years)
   
1.25
     
1.25
 
Volatility
   
37.23
%
   
33.32
%
Risk-free interest rate
   
1.93
%
   
0.93
%
Expected dividend
   
     
 
Weighted average fair value per share of options granted during the period
  $
4.32
    $
6.78
 
  
During the
three
months ended
June 30, 2018
and
2017,
no
shares were issued under the Purchase Plan. During the
six
months ended
June 30, 2018
and
2017,
a total of
108,000
and
100,000
shares, respectively, were issued at a weighted-average purchase price of
$9.29
 and
$9.13
per share, respectively. As of
June 30, 2018,
there was
$1.3
million of unrecognized compensation cost related to the Purchase Plan. That cost is expected to be recognized over a weighted average period of
1.58
years. As of
June 30, 2018,
4.2
million shares were available for future issuance under the Purchase Plan.   
   
Stock Repurchase Program
- On
May 29, 2018,
the Board of Directors terminated the previous
2016
program, and adopted a new
2018
program to repurchase up to
$25.0
million of the Company’s common stock both on the open market and in privately negotiated transactions, from time to time, over the next
two
years. During the
three
and
six
months ended
June 30, 2018,
the Company repurchased
98,800
 and
437,007
shares, respectively, under the
2016
program. As of
June 30, 2018,
1,279,189
shares had been repurchased at an average price of
$14.59
per share under the
2016
program, for a total purchase of
$18.7
million. Under the
2018
program, as of
June
30,.2018,
$25.0
million of the Company’s common stock remained available for future repurchases.